{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:29:14Z","timestamp":1761802154330,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"North Bristol NHS Trust\u2019s Southmead Hospital Charity"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.canep.2019.01.014","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T05:34:49Z","timestamp":1548826489000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Is pleural infection associated with longer survival in mesothelioma? A population-based cohort study using data from Hospital Episode Statistics"],"prefix":"10.1016","volume":"59","author":[{"given":"Anna C.","family":"Bibby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duneesha","family":"de Fonseka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Carslake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/oem.17.4.260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Occup. Environ. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.canep.2019.01.014_bib0010","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","article-title":"British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma","volume":"73","author":"Woolhouse","year":"2018","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.canep.2019.01.014_bib0015","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol."},{"issue":"18_Suppl","key":"10.1016\/j.canep.2019.01.014_bib0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.18_suppl.LBA8507","article-title":"Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: results of the IFCT-1501 MAPS2 randomized phase II trial","volume":"35","author":"Scherpereel","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.canep.2019.01.014_bib0025","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canep.2019.01.014_bib0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the european respiratory society and the European society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0035","first-page":"205","article-title":"The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, MD, reviewed in the light of modern research","volume":"6","author":"Nauts","year":"1946","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canep.2019.01.014_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00199131","article-title":"Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report","volume":"22","author":"Bakker","year":"1986","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-5223(19)39476-0","article-title":"Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer","volume":"81","author":"McKneally","year":"1981","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"7","key":"10.1016\/j.canep.2019.01.014_bib0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/thx.40.7.515","article-title":"Further experience of Corynebacterium parvum in malignant pleural effusion","volume":"40","author":"McLeod","year":"1985","journal-title":"Thorax"},{"key":"10.1016\/j.canep.2019.01.014_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lungcan.2018.06.002","article-title":"Are intra-pleural bacterial products associated with longer survival in adults with malignant pleural effusions? A systematic review","volume":"122","author":"Bibby","year":"2018","journal-title":"Lung Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.canep.2019.01.014_bib0060","first-page":"ii41","article-title":"Management of pleural infection in adults: british Thoracic Society pleural disease guideline 2010","volume":"65","author":"Davies","year":"2010","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.13-1558","article-title":"A Clinical Score (RAPID) to Identify Those at Risk for Poor Outcome at Presentation in Patients With Pleural Infection","volume":"145","author":"Rahman","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.canep.2019.01.014_bib0070","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.chest.2016.12.014","article-title":"Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients","volume":"151","author":"Walker","year":"2017","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.canep.2019.01.014_bib0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM197211162872004","article-title":"Postoperative empyema improves survival in lung cancer: documentation and analysis of a natural experiment","volume":"287","author":"Ruckdeschel","year":"1972","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.canep.2019.01.014_bib0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-5223(19)42423-9","article-title":"Effect of postoperative empyema on survival of patients with bronchogenic carcinoma","volume":"59","author":"Takita","year":"1970","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.canep.2019.01.014_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14017437009131942","article-title":"Postpneumonectomy empyema in pulmonary carcinoma patients","volume":"4","author":"Virkkula","year":"1970","journal-title":"Scand. J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.canep.2019.01.014_bib0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1378\/chest.14-2199","article-title":"Survival in patients with malignant pleural effusions who developed pleural infection: a retrospective case review from six UK centers","volume":"148","author":"Bibby","year":"2015","journal-title":"Chest"},{"year":"2008","author":"National Institute of Health & Care Excellence (NICE)","series-title":"Pemetrexed for the Treatment of Malignant Pleural Mesothelioma. Technology Appraisal Guidance [TA135]","key":"10.1016\/j.canep.2019.01.014_bib0095"},{"issue":"5","key":"10.1016\/j.canep.2019.01.014_bib0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/JTO.0b013e3182862e7e","article-title":"Influence of postoperative infectious complications on long-term survival of lung Cancer patients: a population-based cohort study","volume":"8","author":"Andalib","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"7280","key":"10.1016\/j.canep.2019.01.014_bib0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.322.7280.226","article-title":"Sifting the evidence\u2014what\u2019s wrong with significance tests? Another comment on the role of statistical methods","volume":"322","author":"Sterne","year":"2001","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.canep.2019.01.014_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) Study of 14,228 Patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/0284186X.2012.709948","article-title":"Treatment and survival analyses of malignant mesothelioma in Japan","volume":"52","author":"Gemba","year":"2013","journal-title":"Acta Oncol. (Madr.)"},{"key":"10.1016\/j.canep.2019.01.014_bib0120","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/bjc.2012.408","article-title":"Routes to diagnosis for cancer \u2013 determining the patient journey using multiple routine data sets","volume":"107","author":"Elliss-Brookes","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"90","key":"10.1016\/j.canep.2019.01.014_bib0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.bjc.6601696","article-title":"Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001","author":"Coleman","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"9464","key":"10.1016\/j.canep.2019.01.014_bib0130","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(05)71146-6","article-title":"Social determinants of health inequalities","volume":"365","author":"Marmot","year":"2005","journal-title":"Lancet"},{"issue":"8754","key":"10.1016\/j.canep.2019.01.014_bib0135","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/0140-6736(91)93068-K","article-title":"Health inequalities among British civil servants: the Whitehall II study","volume":"337","author":"Marmot","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0140","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/cam4.1378","article-title":"Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis","volume":"7","author":"Chouaid","year":"2018","journal-title":"Cancer Med."},{"year":"2019","author":"King","series-title":"Cancer Registration Statistics, England","key":"10.1016\/j.canep.2019.01.014_bib0145"},{"year":"2019","author":"Darnton","series-title":"Mesothelioma Mortality in Great Britain 1968\u20132015","key":"10.1016\/j.canep.2019.01.014_bib0150"},{"issue":"3","key":"10.1016\/j.canep.2019.01.014_bib0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canep.2019.01.014_bib0160","first-page":"156406","article-title":"Emergence of parapneumonic empyema in the USA","author":"Grijalva","year":"2010","journal-title":"Thorax"},{"issue":"Suppl. 2","key":"10.1016\/j.canep.2019.01.014_bib0165","first-page":"ii1","article-title":"British thoracic society standards of care C. BTS statement on malignant mesothelioma in the UK","volume":"62","year":"2007","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.canep.2019.01.014_bib0170","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.68.6.3581-3586.2000","article-title":"Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production","volume":"68","author":"Hessle","year":"2000","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.canep.2019.01.014_bib0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.canep.2019.01.014_bib0180","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/CMR.00104-12","article-title":"Staphylococcal and streptococcal superantigen exotoxins","volume":"26","author":"Spaulding","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.canep.2019.01.014_bib0185","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"issue":"9948","key":"10.1016\/j.canep.2019.01.014_bib0190","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(14)60418-9","article-title":"Efficacy and cost of video\u2010assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open\u2010label, randomised, controlled trial","volume":"384","author":"Rintoul","year":"2014","journal-title":"Lancet"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118305976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118305976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:27:02Z","timestamp":1761802022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782118305976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"alternative-id":["S1877782118305976"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2019.01.014","relation":{},"ISSN":["1877-7821"],"issn-type":[{"type":"print","value":"1877-7821"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is pleural infection associated with longer survival in mesothelioma? A population-based cohort study using data from Hospital Episode Statistics","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2019.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}